Swixx BioPharma - Board and Management

Stuart Swanson Chairman, Founder, Head of Corporate Development Co-Founder PharmaSwiss, formerly Head of Marketing at BMS CEE/Israel, GM Pfizer Russia and US Diplomat

Barbara Košir NED, Board Member and Audit Committee Chair Acting Chair of Ethics and Compliance Committee Formerly CFO of PharmaSwiss, prior to that held a series of key Finance positions at Coca Cola, IBM and AGIP

SWIXX BIOPHARMA BOARD

EXECUTIVE MANAGEMENT

Petr Pípal CFO Worked 3 years as CFO of PharmaSwiss and 10 years in senior finance functions in BMS, Member of the Board in Farma- Projekt Poland.

Jean-Michel Lespinasse CEO Worked 6 years as COO of A&D’s Marketing & Sales Division. Was as COO at Delta Medical, and before that was GM BMS Russia.

Dezső Mártha, MD COO, Head of Rare Diseases BU and Alliance Management Head of Celgene CEE until June 2019, prior to that GM BMS Hungary and BMS CEE Indirect Markets (Balkans + Slovakia + Baltics + Malta + Iceland)

Marcela Laššáková Chief Compliance Officer Until July 2016 Director Compliance and Internal Controls Valeant /PharmaSwiss EMEA since 2009. Prior to that Business Control Function Manager BMS Austria & Central Europe.

Gabriela Zelenková Legal Counsel and Secretary Previously BMS Vice-President and Ass. General Counsel, Head of Intercontinental R/C Law Department responsible for 65 markets including CEE, Middle East, Africa and India; China, Pacific Rim, Brazil, Latin America; Before that, BMS Vice-President and Ass. General Counsel, Head of R/C Law department Europe supporting all European countries and Distributor Markets of Europe.

REGIONAL MANAGEMENT

FUNCTIONAL SUPPORT

Predrag Lukić, MPharm General Manager Serbia, Regional Director Montenegro, North Macedonia, Bosnia and Herzegovina, Kosovo Formerly GM PharmaSwiss Serbia. Prior to that held series of BUH and marketing / sales positions in PharmaSwiss Serbia.

Saulius Žemaitis, MD Regional Director Baltic Markets, General Manager Lithuania Until Jan, 2015 Regional GM Baltics at Valeant. Until 2011, GM Lithuania at PharmaSwiss and before that GM Lithuania at BMS. Started as BMS Med. Rep.

Davor Kovačević General Manager Croatia and Slovenia In Pharma industry as of 2002. Formerly Country manager for Croatia and Slovenia in Celgene. Prior to that held various positions in Alpe-Adria region such as Business unit head, Market access head, Marketing and Sales management in rare diseases, hospital, primary care and OTC area.

Martina Bergant General Manager Slovenia Formaly CFO Sanofi for South, East & Central Europe. In pharmaceutical business since 2002, holding different managerial positions covering Slovenia as well as CEE.

Kenan Selmanović General Manager Bosnia & Herzegovina Formerly GM PharmaSwiss/Valeant BiH (2011-2018). Prior to that leading Schering Plough BiH (2008- 2011), held series roles in GSK (2004-2008)

Ivana Prelević General Manager Montenegro Previously GM PharmaSwiss Montenegro 2003-2014 and prior to that GM Pfizer Montenegro.

Žaklina Pop-Simonova General Manager North Macedonia, Kosovo, Albania Formerly GM PharmaSwiss /Valeant Macedonia, Kosovo, Albania (2012-2016). Prior to that GM PharmaSwiss Macedonia & Kosovo (2005-2012), GM Macedonia PharmaSwiss (2000-2005), GM BMS Macedonia (1996-2000). Started in early 1993 as Ostomy and Wound Care Manager for ConvaTec/BMS.

Gergely Kovács General Manager Hungary Eight years of pharma sales & marketing experience as BUD for Pfizer and Krka Hungary. Prior to that, 16 years in different finance/consulting roles including Finance Director for Pfizer Hungary and GM/FD for Tele2.

Gabriela Markovová General Manager Slovakia Former Managing Director at A&D Pharma Marketing & Sales in Slovakia. In the past, BUM onco/orphan, Market Access and Marketing manager onco/orphan at Roche, Celgene and Takeda.

Ivana Pešić, MPharm Director Corporate Regulatory Affairs and Pharmacovigilance Previously Head of Regulatory Affairs at PharmaSwiss Serbia and Reg. Manager, KRKA Serbia.

Marija Nikolić, MD Regional Medical Director, Former Yugoslavia Clinical Pharmacologist. Held series of positions at leading MNCs / Quintiles in Medical and Research. Prior to that Chief of Clincal Pharmacology at Bel. Hosp.

Jelica Čubrić Corporate Head of Quality Assurance Formerly QA Associate Director at Valeant Serbia. Previously held series of Quality/Compliance roles at Donau Labs & Coca Cola.

Meta Gros Head of Logistics Formerly Logistics Coordinator at PharmaSwiss. Prior to that purchase and sales positions in PharmaSwiss.

Ivan Pertot, MPharm Regional BD Director Swixx Brands Previously Head of Regulatory Department for non-EU Balkan countries at PharmaSwiss, prior to that Regulatory Affairs Director (2009-2013) and Regulatory Affairs Manager (2007-2009) at PharmaSwiss Serbia and Regulatory Affairs Officer at Schering Plough Serbia.

Alexander Asam Board Observer More than 20 years experience in the life sciences and private equity business. Formerly various positions at Hoechst, Aventis and Deutsche Bank

Matthias Fehr Board Member Audit Commitee For 17 years investment advisor at HBM Partners. Board observer at PharmaSwiss SA 2007-2011. Formerly Pharma Analyst at Lombard Odier

Petr Čapek, MD General Manager Czech Republic Worked 5 years as GM PharmaSwiss Czech, previously GM Amgen CZ&SK and prior to that worked in various positions at BMS (BUH Oncology/Hospital products & Medical Director) since 1995.

Alexander Marinov General Manager Bulgaria Before joining Swixx Biopharma served as GM A&D Pharma Marketing and Sales Bulgaria for the last 7 years. Prior to that, BUH Hospital and Specialized products within A&D Pharma Bulgaria. Previously held various positions in BMS (BUH Oncology/Hospital products & Medical Director Bulgaria & Romania) since 1996. .

Michal Opuchlik, MD General Manager Poland Formerly Country Manager Alexion Poland, Greece, Cyprus, Israel, Romania and Bulgaria. Prior to that held position of Area General Manager for Poland, Baltic Countries and Russia in AOP Orphan Pharmaceuticals.

Laur Saar, MD Corporate Medical Director, Regulatory & PV Until May 2015 Medical Director of Valeant / Pharma Swiss Europe since 2006. Prior to that Regional Medical BMS Baltics.

Pavel Chistyakov General Manager Russia and Regional Director EurAsia 23+ experience in pharma at executive positions, former General Manager of Ipsen in Russia and CIS (9Y), Pierre Fabre General manager Russia (7Y), Sanofi Trade and Revenue head Russia and EurAsia (5Y) and before joining Swixx Biopharma was Commercial VP for Greece, Russia and Turkey in Italpharmaco. .

Benoit Chastaing Board Member

Marie-Justine Lecomte Board Observer 6+ years’ experience in Private Equity and M&A specialized in healthcare transactions. Former position in investment at Gimv

George Bithas General Manager Greece, Cyprus and Malta More than 20 years experience in pharma industry, holding a series of roles with increasing responsibility in hospital devices, medical nutrition and specialty care in Abbott & AbbVie for Greece and Cyprus. Most recently served as Business Unit Director Immunology.

Petr Němec Founder, Strategy Co-Founder PharmaSwiss, formerly GM BMS South East Europe. Previously Sr. Executive Convatec CEE & Lawyer at White & Case

25 years’ experience in M&A transactions and Investment area including operational experiences. 10 years of successful private equity investment in the healthcare sector, two main experiences as Manager/Investor under LBO. Former various position at Medipole Partnaires (Elsan) and Senior Healthcare Partner at Gimv

Tomas Cernik Chief of Staff to CEO, Special Projects Lead and GM Romania & Moldova Formerly Country Manager of Bristol-Myers Squibb, responsible for Austria, before that for Czech Republic and Hungary. Prior to this held various commercial and finance positions at BMS in different Central European countries

A Swiss-based Pharmaceutical Company